Cargando…
Cardamonin inhibits the progression of oesophageal cancer by inhibiting the PI3K/AKT signalling pathway
Background: Oesophageal cancer is the most common malignant tumour with a poor prognosis, and the current treatment methods are limited. Therefore, identifying effective treatment methods has become a research hotspot. Cardamonin (CAR) is a natural chalcone compound and has been reported to play an...
Autores principales: | Wang, Zijie, Liu, Hui, Hu, Qing, Shi, Lei, Lü, Muhan, Deng, Mingming, Luo, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120183/ https://www.ncbi.nlm.nih.gov/pubmed/33995637 http://dx.doi.org/10.7150/jca.55519 |
Ejemplares similares
-
Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway
por: Qi, Xiaoyi, et al.
Publicado: (2023) -
Astilbin-induced inhibition of the PI3K/AKT signaling pathway decelerates the progression of osteoarthritis
por: Chen, Chunlin, et al.
Publicado: (2020) -
Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
por: Tong, Chenhao, et al.
Publicado: (2021) -
Knockdown of FUT11 inhibits the progression of gastric cancer via the PI3K/AKT pathway
por: Cao, Wenpeng, et al.
Publicado: (2023) -
Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR Activity
por: Niu, Pei-Guang, et al.
Publicado: (2015)